XOMA Royalty Corp - 8-K Filing
XOMA Royalty Corp entered into Amendment No. 1 to its April 27, 2026 Agreement and Plan of Merger with Ligand Pharmaceuticals Incorporated on May 16, 2026, adding XOMA Royalty Holdings Corporation as a party. The amendment is part of the Holding Company Reorganization under Nevada law in preparation for a merger where Flex Merger Sub will merge into HoldCo, making it a wholly-owned subsidiary of Ligand. (Items: 1.01 Entry Into a Material Definitive Agreement, 9.01 Financial Statements and Exhibits)
Tickers: $XOMA